Unknown

Dataset Information

0

Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.


ABSTRACT: COVID-19 pandemic is spreading rapidly worldwide, and drug selection can affect the morbidity and mortality of the disease positively or negatively. Alpha-lipoic acid (ALA) is a potent antioxidant and reduces oxidative stress and inhibits activation of nuclear factor-kappa B (NF-kB). ALA reduces ADAM17 activity and ACE2 upregulation. ALA is known to have antiviral effects against some viruses. ALA may show antiviral effect by reducing NF-kB activation and alleviating redox reactions. ALA increases the intracellular glutathione strengthens the human host defense. ALA activates ATP dependent K+ channels (Na+, K+-ATPase). Increased K+ in the cell raises the intracellular pH. As the intracellular pH increases, the entry of the virus into the cell decreases. ALA can increase human host defense against SARS-CoV-2 by increasing intracellular pH. ALA treatment increases antioxidant levels and reduces oxidative stress. Thus, ALA may strengthen the human host defense against SARS-CoV-2 and can play a vital role in the treatment of patients with critically ill COVID-19. It can prevent cell damage by decreasing lactate production in patients with COVID-19. Using ALA with insulin in patients with diabetes can show a synergistic effect against SARS-CoV-2. We think ALA treatment will be beneficial against COVID-19 in patients with diabetes.

SUBMITTER: Cure E 

PROVIDER: S-EPMC7427590 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.

Cure Erkan E   Cumhur Cure Medine M  

Medical hypotheses 20200814


COVID-19 pandemic is spreading rapidly worldwide, and drug selection can affect the morbidity and mortality of the disease positively or negatively. Alpha-lipoic acid (ALA) is a potent antioxidant and reduces oxidative stress and inhibits activation of nuclear factor-kappa B (NF-kB). ALA reduces ADAM17 activity and ACE2 upregulation. ALA is known to have antiviral effects against some viruses. ALA may show antiviral effect by reducing NF-kB activation and alleviating redox reactions. ALA increas  ...[more]

Similar Datasets

| S-EPMC7361449 | biostudies-literature
| S-BSST563 | biostudies-other
| S-EPMC10828055 | biostudies-literature
| S-EPMC10009350 | biostudies-literature
| S-EPMC7292051 | biostudies-literature
| S-EPMC7270579 | biostudies-literature
| S-EPMC7519863 | biostudies-literature
| S-EPMC7494705 | biostudies-literature
| S-EPMC9416995 | biostudies-literature
| S-EPMC6541350 | biostudies-literature